Median Technologies

Median Technologies eyonis™ LCS Hits Primary Endpoint in RELIVE Trial, Final Step for Regulatory Submission

Median Technologies has announced a significant milestone in its mission to revolutionize lung cancer screening. The company’s proprietary artificial intelligence (AI) and machine learning (ML)-based software, eyonis™ Lung Cancer Screening…

Read MoreMedian Technologies eyonis™ LCS Hits Primary Endpoint in RELIVE Trial, Final Step for Regulatory Submission